Table 1

Trial interventions in the five randomisation groups

GroupCNTBS
IMPColostrumN-acetyl glucosamineTeduglutideBudesonideStandard care
PresentationPowder in capsulesPowder in capsulesAmpoulesLiquid–
Number of patients4545454545
Dose     
 days 1–71.5 g three times a day300 mg three times a day0.05 mg/kg daily1 mg three times a day–
 days 8–11
 days 12–14		1.5 g three times a day
1.5 g three times a day		600 mg three times a day
600 mg three times a day		0.05 mg/kg daily
0.05 mg/kg daily		1 mg two times per day
0.5 mg two times per day		–

  • All IMPs are to be given for 14 days.

  • IMP, Investigational product.